Your browser doesn't support javascript.
loading
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population.
Fancelli, Sara; Caliman, Enrico; Mazzoni, Francesca; Paglialunga, Luca; Gatta Michelet, Marta Rita; Lavacchi, Daniele; Berardi, Rossana; Mentrasti, Giulia; Metro, Giulio; Birocchi, Ilaria; Delmonte, Angelo; Priano, Ilaria; Comin, Camilla Eva; Castiglione, Francesca; Bartoli, Caterina; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo.
Afiliación
  • Fancelli S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Caliman E; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Mazzoni F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Paglialunga L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Gatta Michelet MR; Medical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Lavacchi D; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Berardi R; Medical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Mentrasti G; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Metro G; Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria (AOU) Ospedali Riuniti di Ancona, Ancona, Italy.
  • Birocchi I; Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria (AOU) Ospedali Riuniti di Ancona, Ancona, Italy.
  • Delmonte A; Medical Oncology Unit, Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Priano I; Medical Oncology Unit, Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Comin CE; Scientific Institute of Romagna for the Study and Treatment of Tumors (IRST) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy.
  • Castiglione F; Scientific Institute of Romagna for the Study and Treatment of Tumors (IRST) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy.
  • Bartoli C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Voltolini L; Surgery, Histopathology and Molecular Pathology Unit, Careggi University Hospital, Florence, Italy.
  • Pillozzi S; Pathological Histology and Molecular Diagnostics Unit, Careggi University Hospital, Florence, Italy.
  • Antonuzzo L; Pathological Histology and Molecular Diagnostics Unit, Careggi University Hospital, Florence, Italy.
Front Oncol ; 12: 968064, 2022.
Article en En | MEDLINE | ID: mdl-36452502
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia